Idya mamwe walnuts ekukubatsira kuti ugare kure nekenza yakajeka

Share This Post

Nut-rich diets, such as walnuts, have been shown to play a role in heart health and reducing colorectal cancer. According to a new study, the impact of walnuts on intestinal microbes and the existence of trillions of microbes or bacteria in the gastrointestinal tract may be some of the health benefits. Research results published in the Journal of Nutrition show that edible walnuts not only affect the secondary bile acids produced by intestinal flora and microorganisms, but also reduce the LDL-cholesterol levels of adults participating in the study. Gastrointestinal health is good.

"Takaona kuti kana iwe uchidya walnuts, inowedzera hutachiona hunogadzira butyric acid, inova iyo inobatsira metabolite inobatsira hutano hwekoloni." Naizvozvo, kudyidzana kwema walnuts ne microbiome kunobatsira kuburitsa mimwe mitezo yehutano, "akadaro Hannah Holscher.

 

In this study, the diet of 18 healthy male and female adults included 0 grams of walnuts or 42 grams—about one-third of a cup or more walnuts in one palm—for two or three weeks. Fecal and blood samples were collected at the beginning and end of each phase to assess the secondary results of the study, including the impact of walnut consumption on fecal microorganisms and bile acids and healthy metabolic markers. The consumption of walnuts leads to the relative abundance of three bacteria of interest: fecal bacteria, red blood cells, and Clostridium.

The results also showed that compared with the control group, the consumption of walnuts reduced secondary bile acids. Hannah Holscher explained that people with a higher incidence of kenza yakajeka have higher levels of secondary bile acids. Secondary bile acids can damage cells in the gastrointestinal tract, and microorganisms can produce secondary bile acids. If we can reduce the secondary bile acid in the intestines, it can also help human health.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa